Siddiqi, Shan H. http://orcid.org/0000-0002-0967-9289
Khosravani, Sanaz
Rolston, John D.
Fox, Michael D. http://orcid.org/0000-0001-8848-6399
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K23MH121657, R01MH113929)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (K23NS114178)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 18 March 2023
Revised: 7 July 2023
Accepted: 10 July 2023
First Online: 31 July 2023
Competing interests
: SHS and MDF are scientific consultants for Magnus Medical. SHS is a clinical consultant for Acacia Mental Health, Kaizen Brain Center, and Boston Precision Neurotherapeutics. SHS and MDF have jointly received investigator-initiated research funding from Neuronetics. SHS has served as a speaker for Brainsway and PsychU.org (unbranded, sponsored by Otsuka). SHS and MDF independently own intellectual property involving the use of functional connectivity to target TMS. JDR has previously consulted for Medtronic, Neuropace, and Corlieve Therapeutics. SK has no competing interests.